Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Effectiveness and Safety of First-line Tenofovir + Emtricitabine + Efavirenz for Patients With HIV: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438093/all/Immediate_versus_delayed_treatment_for_recently_symptomatic_carotid_artery_stenosis_New. Accessed 28 March 2024.
Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438093/all/Immediate_versus_delayed_treatment_for_recently_symptomatic_carotid_artery_stenosis_New. Accessed March 28, 2024.
Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438093/all/Immediate_versus_delayed_treatment_for_recently_symptomatic_carotid_artery_stenosis_New
Effectiveness and Safety of First-line Tenofovir + Emtricitabine + Efavirenz for Patients With HIV: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438093/all/Immediate_versus_delayed_treatment_for_recently_symptomatic_carotid_artery_stenosis_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV: Cochrane systematic review
ID - 438093
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438093/all/Immediate_versus_delayed_treatment_for_recently_symptomatic_carotid_artery_stenosis_New
DB - Evidence Central
DP - Unbound Medicine
ER -